Wu H - Search Results

1

Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.

Wu H, Dmitriev I, Kashentseva E, Seki T, Wang M, Curiel DT. Wu H, et al. J Virol. 2002 Dec;76(24):12775-82. doi: 10.1128/jvi.76.24.12775-12782.2002. J Virol. 2002. PMID: 12438602 Free PMC article.

2

Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency.

Wu H, Seki T, Dmitriev I, Uil T, Kashentseva E, Han T, Curiel DT. Wu H, et al. Hum Gene Ther. 2002 Sep 1;13(13):1647-53. doi: 10.1089/10430340260201734. Hum Gene Ther. 2002. PMID: 12228019

3

Identification of sites in adenovirus hexon for foreign peptide incorporation.

Wu H, Han T, Belousova N, Krasnykh V, Kashentseva E, Dmitriev I, Kataram M, Mahasreshti PJ, Curiel DT. Wu H, et al. J Virol. 2005 Mar;79(6):3382-90. doi: 10.1128/JVI.79.6.3382-3390.2005. J Virol. 2005. PMID: 15731232 Free PMC article.

4

Fiber-modified adenoviruses for targeted gene therapy.

Wu H, Curiel DT. Wu H, et al. Methods Mol Biol. 2008;434:113-32. doi: 10.1007/978-1-60327-248-3_8. Methods Mol Biol. 2008. PMID: 18470642

5

Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX.

Tang Y, Le LP, Matthews QL, Han T, Wu H, Curiel DT. Tang Y, et al. Among authors: wu h. Virology. 2008 Aug 1;377(2):391-400. doi: 10.1016/j.virol.2008.04.023. Virology. 2008. PMID: 18570971 Free article.

6

Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.

Matthews QL, Yang P, Wu Q, Belousova N, Rivera AA, Stoff-Khalili MA, Waehler R, Hsu HC, Li Z, Li J, Mountz JD, Wu H, Curiel DT. Matthews QL, et al. Among authors: wu h, wu q. Virol J. 2008 Aug 21;5:98. doi: 10.1186/1743-422X-5-98. Virol J. 2008. PMID: 18718011 Free PMC article.

7

Double genetic modification of adenovirus fiber with RGD polylysine motifs significantly enhances gene transfer to isolated human pancreatic islets.

Contreras JL, Wu H, Smyth CA, Eckstein CP, Young CJ, Seki T, Bilbao G, Curiel DT, Eckhoff DE. Contreras JL, et al. Among authors: wu h. Transplantation. 2003 Jul 15;76(1):252-61. doi: 10.1097/01.TP.0000066361.02042.CA. Transplantation. 2003. PMID: 12865820

8

Gene transfer to cervical cancer with fiber-modified adenoviruses.

Rein DT, Breidenbach M, Wu H, Han T, Haviv YS, Wang M, Kirby TO, Kawakami Y, Dall P, Alvarez RD, Curiel DT. Rein DT, et al. Among authors: wu h. Int J Cancer. 2004 Sep 20;111(5):698-704. doi: 10.1002/ijc.20295. Int J Cancer. 2004. PMID: 15252838

9

An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles.

Saini V, Martyshkin DV, Mirov SB, Perez A, Perkins G, Ellisman MH, Towner VD, Wu H, Pereboeva L, Borovjagin A, Curiel DT, Everts M. Saini V, et al. Among authors: wu h. Small. 2008 Feb;4(2):262-9. doi: 10.1002/smll.200700403. Small. 2008. PMID: 18200644

10

Development of an optimized conditionally replicative adenoviral agent for ovarian cancer.

Zhu ZB, Lu B, Park M, Makhija SK, Numnum TM, Kendrick JE, Wang M, Tsuruta Y, Fisher P, Alvarez RD, Zhou F, Siegal GP, Wu H, Curiel DT. Zhu ZB, et al. Among authors: wu h. Int J Oncol. 2008 Jun;32(6):1179-88. doi: 10.3892/ijo_32_6_1179. Int J Oncol. 2008. PMID: 18497979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,809 results

Search Page

Filters